Results of a study with Mogamulizumab combined with chemotherapy for first line treatment of adult t-cell lymphoma.
Home / Resource Library / Mogamulizumab Plus EPOCH Therapy for Patients With Newly Diagnosed Aggressive Adult T-cell Leukemia/lymphoma